Semaglutide (Ozempic®): A Comprehensive Review and Options

Semaglutide (Ozempic®): A Comprehensive Review and Options

Semaglutide, a glucagon-like peptide 1 (GLP-1), has shown great potential in treating various conditions related to obesity, Nonalcoholic Steatohepatitis (NASH), neurodegenerative and cardiovascular disease. Compared to other GLP-1 receptor agonists like liraglutide, Semaglutide demonstrated more potency and achieved a weight loss of 15.8% over 6.4% with liraglutide. Furthermore, papers showed a 24% reduction in various […]